SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John H. Farro who wrote (1399)1/26/1997 10:26:00 AM
From: Richard Mazzarella   of 4342
 
Robin, I am still following this stock very closely. Investors should be aware that the 3 drug cocktail is now showing failure as an AIDs cure. News reports have 1/3 of all users of the cocktail now failing. Some are never helped in the first place. What is especially distressing is that HIV is now becoming even more resistant than before the cocktail, scary. What this means for the success of Androvir I don't know, but it should raise some caution. If the PRLN pathway doesn't have these problems of protease, PRLN could be a real winner. However, HIV does seem to have science struggling with the same problems for all current approaches. Just some thoughts.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News